AbCellera Biologics Inc. ABCL Pre-Tax Income (Domestic)
Pre-Tax Income (Domestic) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s pre-tax income (domestic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s pre-tax income (domestic)?
- AbCellera Biologics Inc. (ABCL) reported pre-tax income (domestic) of -$47.12M in Q4 2025.
- How has AbCellera Biologics Inc.'s pre-tax income (domestic) changed year-over-year?
- AbCellera Biologics Inc.'s pre-tax income (domestic) increased by 0.5% year-over-year, from -$47.37M to -$47.12M.
- What is the long-term trend for AbCellera Biologics Inc.'s pre-tax income (domestic)?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s pre-tax income (domestic) has grown at a 13.5% compound annual growth rate (CAGR), from -$146.32M to -$188.46M.
- What does pre-tax income (domestic) mean?
- The pre-tax earnings generated from the company's core domestic business activities. It isolates the profitability of operations within the home country, excluding the effects of international tax jurisdictions.